Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3,938,449
-
Total 13F shares
-
706,945
-
Share change
-
+90,776
-
Total reported value
-
$1,392,679
-
Price per share
-
$1.97
-
Number of holders
-
19
-
Value change
-
+$165,896
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) as of Q4 2025
As of 31 Dec 2025,
KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
706,945 shares.
The largest 10 holders included
ADAR1 Capital Management, LLC, Stonepine Capital Management, LLC, DRW Securities, LLC, Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and XTX Topco Ltd.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.